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astolic	 function	was	primarily	defined	using	E/é-	ratio	 (population	mean	4.8,	 range	
2.1–9.0).	 In	 a	 multivariate	 model,	 systolic	 blood	 pressure	 (P	<	0.005),	 female	 sex	






tolic	 blood	pressure	 and	 age.	 In	 conclusion,	we	 identified	 systolic	 blood	pressure,	





failure	with	 preserved	 LV	 systolic	 function	 but	 decreased	 LV	 dia-








In	 previous	 studies	 among	 elderly	 populations,	 hypertension,	
obesity,	 diabetes,	 ventricular	 remodeling,	 and	 high	 age	 have	 been	
found	 to	 associate	 with	 worse	 LV	 diastolic	 dysfunction.3,4	 Even	
though	 the	 origins	 of	 decreased	 LV	 diastolic	 function	 in	 later	 life	
are	suggested	to	stem	from	lifestyle	factors	exerting	their	influence	
during	 the	whole	 life	 course,	 the	 links	between	 these	 factors	 and	
LV	diastolic	 function	 in	clinically	healthy	adult	population	have	re-
mained	obscure.	To	address	this	paucity	of	knowledge,	we	identified	
the	 determinants	 of	 LV	 diastolic	 function	 leveraging	 the	 echocar-



















measurements,	 severe	 cardiovascular	 diseases	 (including	 stroke,	
myocardial	 infarction,	 atrial	 fibrillation,	 unstable	 angina	 pecto-
ris,	 cardiomyopathies,	 and	 regurgitation	 or	 stenosis	 of	 mitral	 or	
aortic	 valve),	 the	 study	population	of	 the	 present	 study	 consisted	




inations	 at	 five	 YFS	 study	 centers	 in	 Finland.	 Transthoracic	 echo-





CommPACS	 10.7.8	 (MediMatic	 Solutions,	 Genova,	 Italy)	 analysis	
program.7	We	included	the	study	center	as	a	technical	covariate	in	
the	 statistical	models	 to	ensure	 that	 the	 results	 are	not	driven	by	
differences	between	the	centers.
E/é-	ratio,	 a	 noninvasive	 measurement	 representing	 LV	 filling	
pressure	 in	 early	 diastole,	was	used	 as	 an	 indicator	of	 LV	diastolic	
function	in	the	present	study.	Pulsed-	wave	Doppler	imaging	was	used	













Left	 ventricular	 mass	 was	 calculated	 as	 (0.8[1.04((LV	 end-	
diastolic	 diameter	+	end-	diastolic	 posterior	 wall	 thickness	+	end-	
diastolic	 inter-	ventricular	 septum	 thickness)3	–	LV	 end-	diastolic	
diameter)3]	+	0.6	g.	 Relative	 wall	 thickness	 was	 calculated	 as	 (2×	
end-	diastolic	 posterior	 wall	 thickness)/LV	 end-	diastolic	 diameter.	
The	LV	geometry	groups	were	defined	by	the	population	85th	per-
centile	 cut-	offs	 values	 for	 LV	hypertrophy	 (indexed	 LV	mass/BSA)	
and	relative	wall	thickness.	Concentric	remodeling	is	defined	as	high	
relative	wall	thickness	without	LV	hypertrophy.	Eccentric	hypertro-
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index	 ranging	 between	 5–15),	 and	 alcohol	 consumption	 (standard	
drinks/day)	 were	 collected	 using	 questionnaires.9	 Using	 the	 data	
from	the	follow-	up	studies	 in	2001,	2007	and	2011,	diabetes	mel-
litus	was	defined	as	 (a)	 fasting	serum	glucose	over	7.0	mmol/L,	 (b)	
hemoglobin	A1c	over	6.5%,	(c)	use	of	insulin	or	per	oral	antidiabetic	
agents,	or	(d)	a	previous	diagnosis	of	diabetes	mellitus.







diabetes	 mellitus,	 (c)	 hypertriglyceridemia	≥	1.7	mmol/L	 and	 high-	
density	 lipoprotein	cholesterol	 (HDL-	C)	 levels	<	1.0	mmol/L	in	men	











immunoturbidimetrically.12	 The	 concentration	 of	 serum	 insu-
lin	was	 determined	with	 an	 immunoassay.12	 Homeostasis	model	
assessment-	estimated	insulin	resistance	(HOMA-	IR)	was	calculated	
as	(insulin	×	fasting	serum	glucose)/22.5.13	Fasting	serum	glucose,	
alanine	 aminotransferase	 (ALT),	 gamma-	glutamyltransferase	
(GGT),	 total	 cholesterol,	 HDL-	C,	 and	 triglyceride	 concentrations	
were	 measured	 by	 enzymatic	 methods.12	 Low-	density	 lipopro-




Chronic	 Kidney	 Disease	 Epidemiology	 Collaboration	 equation.16 









while	 an	 independent	 2-	group	 Mann-	Whitney	 U-	Test	 was	 used	
for	 continuous	 variables	with	 skewed	 distribution.	 For	 categori-
cal	 variables,	 a	Pearson's	 chi-	squared	 test	with	Yates’	 continuity	






















model.	A	 similar	multivariate	model	was	 conducted	 separately	 for	
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3  | RESULTS
The	 characteristics	 of	 the	 study	 population	 are	 described	 in	
Table	S1.	The	prevalence	of	obesity	 (BMI	>	30)	 in	 the	 study	pop-
ulation	 was	 20%.	 In	 the	 whole	 population,	 the	 E/é-	ratio	 values	
ranged	 between	 2.1	 and	 9.0,	 with	 a	 mean	 value	 of	 4.8.	Women	
had	 higher	 E/é-	ratio	 than	men	 (5.0	±	1.0	 vs	 4.6	±	0.9;	P	<	0.005).	
Age	 was	 directly	 associated	 with	 E/é-	ratio	 in	 both	 sexes	 (men,	
β = 0.020; women; β	=	0.048).	 A	 statistically	 significant	 interac-
tion	 term	 (age	*	sex	P	=	0.003)	 indicated	 a	more	 pronounced	 age	
effect	in	women	than	in	men	(Figure	1).	In	men,	one	SD	increase	in	
age	(ie,	5	years)	was	found	to	be	associated	with	~0.1	SD	increase	
in	E/é-	ratio	while	 the	 increase	was	~0.2	SD	 in	women	 (Figure	2).	
Furthermore,	similar	results	were	found	between	age	and	systolic	
blood	pressure:	a	more	pronounced	age	effect	was	found	in	women	
than	 in	men	 (β	=	0.78,	SE	=	0.082	 in	women;	β	=	0.38,	SE	=	0.089	
in	men).
In	 univariate	 regression	 analyses	 in	 the	 whole	 study	 popula-
tion,	E/é-	ratio	was	directly	associated	with	age,	LV	mass,	systolic	
blood	pressure,	diastolic	blood	pressure,	weight,	waist	circumfer-






The	 results	 of	multivariate	 linear	 regression	 analyses	 for	 E/é-	





tended	 to	 associate	 directly	with	 E/é-	ratio	 (P	=	0.08).	No	 statisti-
cally	 significant	 multivariable	 associations	 were	 found	 for	 other	
determinants.	 In	 the	 analyses	 for	 E/A-	ratio,	 age,	 systolic	 blood	
pressure,	and	waist	circumference	were	 inversely	associated	with	
E/A-	ratio,	whereas	female	sex,	LV	mass,	and	physical	activity	were	
directly	 associated	 with	 E/A-	ratio.	 LAVi	 was	 directly	 associated	





models,	 insulin	 was	 inversely	 associated	 with	 E/A-	ratio	 and	 LAVi	
(P	<	0.005	for	both),	whereas	no	association	was	found	for	E/é-	ratio	
(P	=	0.6).	When	systolic	blood	pressure,	waist	 circumference,	 total	
cholesterol,	 and	 fasting	 serum	glucose	were	 replaced	with	 the	di-
agnosis	 of	 the	metabolic	 syndrome	 in	 the	multivariate	model,	 the	
metabolic	 syndrome	 was	 found	 to	 have	 a	 significant	 association	
with	 higher	 E/é-	ratio	 (unadjusted	 mean	 values	 between	 groups:	
5.05	±	1.02	 vs	 4.74	±	1.02)	 and	 lower	 E/A-	ratio	 (1.40	±	0.32	 vs	
1.59	±	0.41)	 (multivariate	P	<	0.005	 for	 both),	whereas	no	 associa-
tion	was	found	for	LAVi	(22.79	±	6.56	vs	22.49	±	6.39)	(P	=	0.2).
The	 results	 from	 the	 analyses	 comparing	 each	 specific	 cardiac	
remodeling	 group	 (ie,	 concentric	 hypertrophy,	 eccentric	 hypertro-
phy	 and	 concentric	 remodeling)	 to	 the	 normal	 cardiac	 geometry	
group	are	shown	in	Figure	3.	The	study	participants	with	concentric	
hypertrophy	 had	 the	 highest	mean	E/é-	ratio	 values.	 Furthermore,	
compared	 to	 participants	 with	 normal	 cardiac	 geometry,	 partici-
pants	with	concentric	hypertrophy	had	a	higher	mean	systolic	blood	
pressure	(118	±	13.8	vs	125	±	16.3	mm	Hg,	P	=	0.016).	Additionally,	
E/é-	ratio	 correlated	 significantly	 with	 the	 following	 cardiac	 mea-
surements:	deceleration	time,	LV	diastolic	volume,	LA	systolic	vol-
ume,	relative	wall	thickness,	and	diastolic	posterior	wall-	and	septum	
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4  | DISCUSSION
Our	 study	 revealed	 several	 potential	 determinants	 of	 impaired	 LV	
diastolic	 function	 in	a	population	of	34–49-	year-	old	 individuals.	 In	






































changes	 in	 intra-	cellular	 calcium	 homeostasis,	 progressive	 thick-













β- estimate SE P- value β- estimate SE P- value β- estimate SE P- value
Female	sex 0.443 0.081 <0.005 0.099 0.034 <0.005 −0.465 0.496 0.348
Age	(years) 0.019 0.006 <0.005 −0.016 0.002 <0.005 0.121 0.041 <0.005
LV	mass	(g) 0.002 0.001 0.081 0.001 0.000 <0.005 0.050 0.006 <0.005
Systolic	blood	pressure	(mm	Hg) 0.011 0.002 <0.005 −0.004 0.001 <0.005 0.044 0.012 <0.005
Height	(cm) −0.018 0.004 <0.005 0.002 0.002 0.289
Waist	circumference	(cm) 0.005 0.002 0.024 −0.006 0.001 <0.005
Glomerular	filtration	rate	(mL/
min/1.73 m2)
−0.004 0.005 0.443 −0.001 0.002 0.582 0.123 0.037 <0.005
ALTb	(U/I) 0.100 0.047 0.032 −0.031 0.020 0.107 −0.471 0.313 0.133
Total	cholesterol	(mmol/L) 0.005 0.024 0.836 −0.015 0.010 0.128 −0.146 0.166 0.380
Fasting	serum	glucoseb	(mmol/L) 0.146 0.186 0.434 −0.065 0.078 0.406 −2.479 1.326 0.062
Smoking	(yes/no) 0.140 0.064 0.028 −0.022 0.027 0.400 0.219 0.444 0.623
Alcohol	consumptionc 0.011 0.021 0.604 0.010 0.009 0.267 0.140 0.145 0.334
Leisure-	time	physical	activity	
indexd
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creating	the	sex	difference	is	most	likely	multifactorial,	and	not	due	
only	to	the	loss	of	the	cardioprotective	effects	of	estrogens.
Active	 smoking	was	 associated	with	 lower	 LV	 function	 inde-
pendent	of	the	other	determinants.	Previous	studies	have	shown	
an	association	between	smoking	and	a	higher	risk	for	the	incidence	
of	heart	 failure	 independent	of	coronary	artery	disease.26 In the 
study	by	Nadruz	et	al,27	active	smoking	and	cumulative	cigarette	
exposure	were	associated	with	subtle	alterations	 in	LV	structure	





hypothesized	 that	 increased	 blood	 pressure	 or	 other	 coexisting	
risk	factors,	such	as	alcohol	consumption	or	lower	physical	activity	
level,	could	confound	smoking-	associated	decrease	on	LV	diastolic	
function.27,28	However,	 our	 results	 do	 not	 support	 confounding.	
We	were	able	to	take	into	account	a	wide	array	of	potential	con-
founders	 and	 still	 smoking	 remained	 independently	 associated	
with	a	lower	diastolic	function.













demonstrating	 an	 independent	 association	 between	 elevated	 ALT	
and	LV	diastolic	 function	 suggest	 that	hepatic	manifestations	may	
play	a	 role	or	 coincide	with	 the	development	of	LV	diastolic	 func-








sociated	 with	 impaired	 LV	 diastolic	 function	 in	 a	 Korean	 popula-
tion,	and	stronger	effects	were	seen	for	E/A-	ratio	than	E/é-	ratio.	In	
several	previous	studies,	insulin	resistance	and	diabetes	have	been	
shown	 to	be	 linked	with	alterations	 in	 cardiac	 structure	and	 func-
tion.36,37	Several	 factors	may	explain	 the	structural	and	functional	
changes,	 including	hyperglycemia,	 coronary	microvascular	disease,	
autonomic	 neuropathy,	 altered	 cardiac	 progenitor	 cell	 function,	
and	renin-	angiotensin-	aldosterone	system	activation.36	The	precise	
pathophysiologic	mechanisms	behind	these	links,	however,	are	not	
understood.	 Furthermore,	 both	 E/A-	ratio	 and	 LAVi	 were	 signifi-
cantly	associated	with	physical	activity,	which	 is	previously	known	
to	cause	alterations	in	cardiac	structure,	and	enlargement	of	LA.38 





There	 are	 some	 limitations	 in	 our	 study	 that	 need	 to	 be	 dis-
cussed.	One	potential	limitation	is	a	possible	selection	of	the	study	
population.	As	in	every	longitudinal	study,	there	is	a	loss	to	follow-	up	
in	 the	YFS.	However,	 detailed	 assessments	 of	 the	 representative-
ness	have	previously	demonstrated	that	there	are	no	significant	dif-
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populations.	 Furthermore,	 since	 the	 LV	 function	 and	 LV	 structure	
measurements	have	been	measured	thus	far	only	once	in	our	cohort,	
we	were	 not	 able	 to	 evaluate	 longitudinal	 changes	 in	 LV	 diastolic	
function	or	LV	hypertrophy	in	our	population.	Future	follow-	ups	is	
needed	 to	provide	 insights	 on	whether	 the	 LV	 function	measured	
in	asymptomatic	 individuals	 is	of	value	 in	predicting	which	part	of	
our	 study	 population	 will	 develop	 clinically	 relevant	 LV	 diastolic	
dysfunction	or	 a	 heart	 failure.	 E/é-	ratio	 is	 the	 best	 available	 non-
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